GRAIL (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 02, 2017
- Vertical
- Life Sciences
- Funding URL
- View Funding Page
- Funding Amount:
- $900,000,000
Company Info
- Founders
- Jeff Huber
- Company Description
- GRAIL is a life sciences company whose mission is to detect cancer early when it can be cured. GRAIL combines the power of high-intensity sequencing (ultra-broad and ultra-deep sequencing), leading-edge computer science, and large population-scale clinical studies to enhance the scientific understanding of cancer biology and develop a blood test for early-stage cancer detection.
- Market
- Cancer Detection
- Location
- Menlo Park, California, USA
- Coinvestors
- Amazon.com, ARCH Venture Partners, Bristol-Myers Squibb, Celgene Corporation, Johnson & Johnson Innovation, McKesson Ventures, Merck Ventures, Tencent Holdings, Varian Medical Systems